# X4 Pharmaceuticals, Inc: Material agreement entered (Form 8-K, 2026-10-08)

**Trigger Strength Score:** 55/100

| Field | Value |
|---|---|
| Company | X4 Pharmaceuticals, Inc |
| Ticker | XFOR |
| CIK | 1501697 |
| Filed | 2026-10-08 |
| Event date | 2026-10-07 |
| Primary trigger | Material agreement entered |
| All items | 1.01 Material agreement entered; 1.02 Material agreement terminated; 2.03 New financing obligation; 3.02 Unregistered equity sale; 7.01 Regulation FD disclosure |
| Location | Boston, MA |
| SIC code | 2836 |
| Accession | 0001501697-26-000081 |

## Why this score
- Primary trigger: Material agreement entered.
- Several material items in one filing.

Source: SEC EDGAR Form 8-K current reports (https://www.sec.gov/Archives/edgar/data/1501697/000150169726000081/xfor-20261007.htm). Last refreshed: 2026-11-04T09:16:40.251Z.
Event classification uses the item numbers companies report on Form 8-K; read the filing itself before acting. Informational only; not investment advice and not an offer or solicitation to buy or sell any security.